NCT00438269View on ClinicalTrials.gov

Pilot Study of the Utility of Empiric Antibiotic Therapy for Suspected ICU-Acquired Infection

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 28, 2003

Study Completion Date

March 31, 2005

Conditions
Nosocomial InfectionPneumoniaSystemic Inflammatory Response SyndromeCritical IllnessPyrexia
Interventions
DRUG

Site-specific empiric regimens included: Meropenem

DRUG

Piperacillin/tazobactam

DRUG

Ciprofloxacin and cefazolin +/- metronidazole

Trial Locations (1)

M5G 2C4

University Health Network, Toronto

All Listed Sponsors
collaborator

The Physicians' Services Incorporated Foundation

OTHER

lead

Canadian Critical Care Trials Group

OTHER

NCT00438269 - Pilot Study of the Utility of Empiric Antibiotic Therapy for Suspected ICU-Acquired Infection | Biotech Hunter | Biotech Hunter